Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-31

FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's rizatriptan benzoate as an original generic application for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan benzoate (generic) (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)